645 related articles for article (PubMed ID: 12182963)
1. Cannabinoids and multiple sclerosis.
Pertwee RG
Pharmacol Ther; 2002 Aug; 95(2):165-74. PubMed ID: 12182963
[TBL] [Abstract][Full Text] [Related]
2. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of cannabinoids in CNS disease.
Croxford JL
CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids control spasticity and tremor in a multiple sclerosis model.
Baker D; Pryce G; Croxford JL; Brown P; Pertwee RG; Huffman JW; Layward L
Nature; 2000 Mar; 404(6773):84-7. PubMed ID: 10716447
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Rice J; Cameron M
Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
[TBL] [Abstract][Full Text] [Related]
6. The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews.
Nielsen S; Germanos R; Weier M; Pollard J; Degenhardt L; Hall W; Buckley N; Farrell M
Curr Neurol Neurosci Rep; 2018 Feb; 18(2):8. PubMed ID: 29442178
[TBL] [Abstract][Full Text] [Related]
7. Towards cannabis and cannabinoid treatment of multiple sclerosis.
Croxford JL; Miller SD
Drugs Today (Barc); 2004 Aug; 40(8):663-76. PubMed ID: 15510238
[TBL] [Abstract][Full Text] [Related]
8. [News about therapeutic use of Cannabis and endocannabinoid system].
Duran M; Laporte JR; Capellà D
Med Clin (Barc); 2004 Mar; 122(10):390-8. PubMed ID: 15033046
[TBL] [Abstract][Full Text] [Related]
9. The endocannabinoid system and multiple sclerosis.
Baker D; Pryce G
Curr Pharm Des; 2008; 14(23):2326-36. PubMed ID: 18781983
[TBL] [Abstract][Full Text] [Related]
10. Acute and chronic cannabinoid extracts administration affects motor function in a CREAE model of multiple sclerosis.
Buccellato E; Carretta D; Utan A; Cavina C; Speroni E; Grassi G; Candeletti S; Romualdi P
J Ethnopharmacol; 2011 Feb; 133(3):1033-8. PubMed ID: 21094240
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids in multiple sclerosis: do they have a therapeutic role?
Killestein J; Uitdehaag BM; Polman CH
Drugs; 2004; 64(1):1-11. PubMed ID: 14723555
[TBL] [Abstract][Full Text] [Related]
12. Role of cannabinoids in multiple sclerosis.
Zajicek JP; Apostu VI
CNS Drugs; 2011 Mar; 25(3):187-201. PubMed ID: 21323391
[TBL] [Abstract][Full Text] [Related]
13. [Marihuana and cannobinoids as medicaments].
Tkaczyk M; Florek E; Piekoszewski W
Przegl Lek; 2012; 69(10):1095-7. PubMed ID: 23421098
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances.
Smith PF
Expert Rev Neurother; 2007 Sep; 7(9):1157-63. PubMed ID: 17868014
[TBL] [Abstract][Full Text] [Related]
15. [Cannabinoids in multiple sclerosis -- therapeutically reasonable?].
Trebst C; Stangel M
Fortschr Neurol Psychiatr; 2005 Aug; 73(8):463-9. PubMed ID: 16052440
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.
Zajicek J; Fox P; Sanders H; Wright D; Vickery J; Nunn A; Thompson A;
Lancet; 2003 Nov; 362(9395):1517-26. PubMed ID: 14615106
[TBL] [Abstract][Full Text] [Related]
17. Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
Russo EB
Neurology; 2003 Feb; 60(4):729-30; author reply 729-30. PubMed ID: 12601130
[No Abstract] [Full Text] [Related]
18. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
Smith PF
Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
[TBL] [Abstract][Full Text] [Related]
19. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
[TBL] [Abstract][Full Text] [Related]
20. Cannabis and Cannabinoids in Multiple Sclerosis: From Experimental Models to Clinical Practice-A Review.
Sirbu CA; Georgescu R; Pleşa FC; Paunescu A; Marilena Ţânţu M; Nicolae AC; Caloianu I; Mitrica M
Am J Ther; 2023 May; 30(3):e220-e231. PubMed ID: 37278703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
